Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

FDMTFDMT
Showing 7 of 22 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in 4D MOLECULAR THERAPEUTICS IN

Janus Henderson Group Ltd. holds 5.2M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $48.9M as of 2026-Q1. The position was increased (+13.2% shares). FDMT represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$48.9M

Current Shares

5.2M

Total Value Change

+$14.9M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.2M
+13.2%
$48.9M0.0%$8.46
33
2025-Q4
Increased
4.6M
+164.4%
$34.7M0.0%$7.58
47
2025-Q3
Decreased
1.8M
-0.1%
$15.2M0.0%$8.35
0
2025-Q2
Decreased
1.8M
-7.3%
$6.5M0.0%$3.84
0
2025-Q1
Decreased
1.9M
-16.0%
$6.9M0.0%$3.63
0
2024-Q4
Decreased
2.3M
-28.2%
$12.5M0.0%$5.30
0
2024-Q3
Decreased
3.1M
-1.9%
$33.9M0.0%$10.83
0

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used